Outcome of Board Meeting
Outcome of the meeting of the Board of Directors held on 27th May, 2017.27-05-2017
27-05-2017
Board Meeting On 27Th May, 2017
Meeting of the Board is scheduled to be held on Saturday, the 27th of May, 2017, to consider among other matters, Audited Financial results for the year ended 31st March, 2017.18-05-2017
Certificate Under Regulation 40 For The Year Ended 31St March, 2017
Certificate from Practicing Certificate for Transfer/Transmission/Transposition under regulation 40 of SEBI (LODR) Regulations for the year ended 31st March, 201730-04-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahaveer Chand Bafna26-04-2017
Compliance Certificate For The Year Ended 31St March, 2017
Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 is hereby attached for your reference. Kindly take the same on record.26-04-2017
Shareholding for the Period Ended March 31, 2017
Bafna Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here20-04-2017
Outcome of Committee Meeting
Outcome of Warrant Allotment Committee Meeting held on 18.03.2017 as per the terms of the Offer Letter.18-03-2017
Outcome of Board Meeting
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that, the Board of Directors of the Company in their meeting held on Tuesday, the 14th day of March, 2017 which commenced at 11.00 A.M. and concluded at 12.15 P.M., inter alia transacted the following: 1.Considered and approved the Private Placement Offer Letter (PAS-4) 2.Constituted Warrant Allotment Committee of the Board.14-03-2017
Board Meeting on Mar 14, 2017
Bafna Pharmaceuticals Ltd has informed BSE that the 162nd Board Meeting of the Directors of the Company will be held on March 14, 2017 inter alia, to transact following business1. To consider and approve PRIVATE PLACEMENT OFFER LETTER (Form PAS-4).10-03-2017